A team of AI and medical researchers at startup Ataraxis AI, who are also affiliated with a host of institutions across the U.S., has announced the development of an AI model that they claim is more accurate at predicting the progression rate of breast cancer than standard tests now administered in hospitals.
This article was originally published on MedicalXpress.com